Osaka, Japan - October 19, 2020 - Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Kenzo Sawai) announced the launch date with the below mentioned schedule for Dutasteride Capsules (the branded product: ZAGALLO®).
Dutasteride Capsules are prescribed for the treatment of male pattern alopecia.
|Product Name||Launch Date|
|Dutasteride Capsules 0.5 mg ZA [SAWAI]||November 6, 2020|
The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States.